Showing results (791-800 of 1,351) with videos related to

Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|November 14, 2023
The Effect of BI 730357 (Retinoic Acid-Related Orphan Receptor Gamma t Antagonist, Bevurogant) on the Pharmacokinetics of a Transporter Probe Cocktail, Including Digoxin, Furosemide, Metformin, and Rosuvastatin: An Open-Label, Non-randomized, 2-Period Fixed-Sequence Trial in Healthy SubjectsHeeJae Choi, Fenglei Huang, Mary Flack
Clinical Pharmacology in Drug Development|July 18, 2024
The Bioequivalence of Abexinostat (CRA-024781) Tosylate Tablets (20 mg) in Chinese Healthy Subjects Under Fasting ConditionsXiang Li, Wenqiang Guo, Jian Chen, et al.
Clinical Pharmacology in Drug Development|September 4, 2024
Relative Bioavailability of Sotorasib Following Administration as a Water Dispersion to Healthy Subjects and Compatibility With Enteral AdministrationPanli Cardona, Marintan Spring, Jiemin Bao, et al.
Clinical Pharmacology in Drug Development|September 5, 2024
Bioequivalence of Meloxicam Nanocrystal Injection in Healthy Chinese VolunteersShengling Hu, Xia Liu, Qinghua Wan, et al.
Clinical Pharmacology in Drug Development|May 29, 2024
Enhanced Bioavailability and Reduced Variability of Dasatinib and Sorafenib with a Novel Amorphous Solid Dispersion Technology PlatformHans Lennernäs, Magnus Brisander, Charlotta Liljebris, et al.
Clinical Pharmacology in Drug Development|July 8, 2024
Safety and Pharmacokinetics of a Combined Antioxidant Therapy against Myocardial Reperfusion Injury: A Phase 1 Randomized Clinical Trial in Healthy HumansAbraham I J Gajardo Cortez, José Lillo-Moya, Daniel San-Martín-Martinez, et al.
Clinical Pharmacology in Drug Development|May 15, 2024
Pharmacokinetics and Bioequivalence of Fixed-Dose Combination of Simvastatin and Ezetimibe Tablets: A Randomized, Crossover, Open-Label Study in Healthy VolunteersChuei Wuei Leong, Kar Ming Yee, Tracy Ann Rani, et al.
Clinical Pharmacology in Drug Development|May 16, 2024
Evaluation of the Clinical Drug-Drug Interaction Potential of Pritelivir on Transporters and CYP450 Enzymes Using a Cocktail ApproachMichiel de Vries, Susanne Bonsmann, Jörg Pausch, et al.
Clinical Pharmacology in Drug Development|May 17, 2024
A Model-Informed Drug Development Approach to Design a Phase 3 Trial of Teverelix Drug Product in Advanced Prostate Cancer Patients with Increased Cardiovascular RiskChenna Keshava Reddy Sannala, Carol MacLean, Finn Larsen, et al.
Clinical Pharmacology in Drug Development|May 17, 2024
Concentration-QTc Modeling of the DPP-4 Inhibitor HSK7653 in a First-in-Human Study of Chinese Healthy VolunteersXiaoxu Wang, Hongzhong Liu, Cheng Cui, et al.
Pageof 136